Concord Biotech Limited — Others, 22-03-2025: Trading Window

Concord Biotech Limited has announced a closure of the trading window for its equity shares, effective from 1st April, 2025, until 48 hours post the declaration of the financial results for the quarter and year ending 31st March, 2025. Designated persons and their immediate relatives are prohibited from trading during this period. This measure aligns with the company's internal policies to ensure compliance. Investors may view this as a proactive step to maintain fair trading practices, potentially leading to a positive outlook surrounding the upcoming financial results.